Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northern Trust (NTRS) Change in Accured Expenses (2017 - 2025)

Historic Change in Accured Expenses for Northern Trust (NTRS) over the last 16 years, with Q3 2025 value amounting to $21.5 million.

  • Northern Trust's Change in Accured Expenses rose 133333.33% to $21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 34545.45%. This contributed to the annual value of -$41.9 million for FY2024, which is 14883.45% down from last year.
  • Per Northern Trust's latest filing, its Change in Accured Expenses stood at $21.5 million for Q3 2025, which was up 133333.33% from -$22.2 million recorded in Q2 2025.
  • In the past 5 years, Northern Trust's Change in Accured Expenses registered a high of $80.0 million during Q4 2022, and its lowest value of -$53.8 million during Q2 2024.
  • For the 5-year period, Northern Trust's Change in Accured Expenses averaged around $13.3 million, with its median value being $7.3 million (2021).
  • As far as peak fluctuations go, Northern Trust's Change in Accured Expenses surged by 149285.71% in 2022, and later crashed by 143333.33% in 2024.
  • Northern Trust's Change in Accured Expenses (Quarter) stood at -$11.6 million in 2021, then surged by 789.66% to $80.0 million in 2022, then plummeted by 103.75% to -$3.0 million in 2023, then tumbled by 1433.33% to -$46.0 million in 2024, then soared by 146.74% to $21.5 million in 2025.
  • Its Change in Accured Expenses stands at $21.5 million for Q3 2025, versus -$22.2 million for Q2 2025 and $44.0 million for Q1 2025.